|
US37650A
(en)
|
|
1863-02-10 |
|
Improvement in apparatus for obtaining profiles of submarine beds |
|
US47929A
(en)
|
|
1865-05-30 |
|
Improved grapnel for wells |
|
US36256A
(en)
|
|
1862-08-19 |
|
Improvement in sewing-m ach ines |
|
US5132301A
(en)
|
1983-05-02 |
1992-07-21 |
Merck & Co., Inc. |
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents
|
|
EP0124081A3
(en)
|
1983-05-02 |
1986-11-26 |
Merck & Co. Inc. |
New substituted cephalosporin sulfones as antiinflammatory and antidegenerative agents, pharmaceutical compositions containing the same and processes for making them
|
|
USRE37650E1
(en)
|
1991-05-10 |
2002-04-09 |
Aventis Pharmacetical Products, Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
SG64322A1
(en)
|
1991-05-10 |
1999-04-27 |
Rhone Poulenc Rorer Int |
Bis mono and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US6645969B1
(en)
|
1991-05-10 |
2003-11-11 |
Aventis Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
EP0541042A1
(de)
|
1991-11-05 |
1993-05-12 |
Hoechst Aktiengesellschaft |
Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
|
|
US5656643A
(en)
|
1993-11-08 |
1997-08-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
CA2299286A1
(en)
|
1997-08-09 |
1999-02-18 |
Laramie Mary Gaster |
Bicyclic compounds as ligands for 5-ht1 receptors
|
|
DE10134721A1
(de)
|
2001-07-17 |
2003-02-06 |
Bayer Ag |
Tetrahydrochinoxaline
|
|
JP2005509028A
(ja)
|
2001-10-09 |
2005-04-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アスパラギン酸およびグルタミン酸誘導体ならびにそのジアゾケトン中間体を合成するための方法
|
|
KR100577179B1
(ko)
|
2001-10-30 |
2006-05-10 |
엘지전자 주식회사 |
유기 전계 발광 소자
|
|
US7078409B2
(en)
|
2002-03-28 |
2006-07-18 |
Beta Pharma, Inc. |
Fused quinazoline derivatives useful as tyrosine kinase inhibitors
|
|
DE10239042A1
(de)
|
2002-08-21 |
2004-03-04 |
Schering Ag |
Makrozyclische Pyrimidine, deren Herstellung und Verwendung als Arzneimittel
|
|
RU2351590C2
(ru)
|
2003-02-10 |
2009-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения диариламина
|
|
CN100579965C
(zh)
|
2003-02-10 |
2010-01-13 |
沃泰克斯药物股份有限公司 |
通过使n-芳基氨基甲酸酯与卤代杂芳基反应制备n-杂芳基-n-芳基胺的方法和类似方法
|
|
DE102004009238A1
(de)
|
2004-02-26 |
2005-09-08 |
Merck Patent Gmbh |
Arylamid-Derivate
|
|
ZA200709817B
(en)
|
2005-04-21 |
2009-02-25 |
Serono Lab |
2,3 substituted pyrazine sulfonmides as inhibitors of CRTH2
|
|
KR20080058436A
(ko)
|
2005-10-13 |
2008-06-25 |
와이어쓰 |
글루탐산 유도체의 제조 방법
|
|
US7910595B2
(en)
|
2005-12-21 |
2011-03-22 |
Abbott Laboratories |
Anti-viral compounds
|
|
US8450348B2
(en)
|
2007-02-21 |
2013-05-28 |
Forma Tm, Llc |
Derivatives of squaric acid with anti-proliferative activity
|
|
CN104250269B
(zh)
|
2007-05-21 |
2018-01-05 |
欧司朗Oled股份有限公司 |
磷光金属配位化合物，含其的发射辐射元件和其制备方法
|
|
US9139764B2
(en)
|
2007-09-28 |
2015-09-22 |
Osram Opto Semiconductors Gmbh |
Organic radiation-emitting component
|
|
WO2009069132A2
(en)
|
2007-11-29 |
2009-06-04 |
Ramot At Tel Aviv University Ltd. |
Novel reverse transcriptase inhibitors
|
|
AU2008335761B2
(en)
|
2007-12-13 |
2014-04-24 |
Merck Sharp & Dohme Corp. |
Inhibitors of janus kinases
|
|
SG165655A1
(en)
*
|
2008-04-16 |
2010-11-29 |
Portola Pharm Inc |
2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
|
|
US20130225527A1
(en)
|
2008-05-21 |
2013-08-29 |
Ariad Pharmaceuticals, Inc. |
Phosphorus Derivatives as Kinase Inhibitors
|
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
|
MX353308B
(es)
|
2008-05-21 |
2018-01-08 |
Ariad Pharma Inc |
Derivados fosforosos como inhibidores de cinasa.
|
|
US20130225528A1
(en)
|
2008-05-21 |
2013-08-29 |
Ariad Pharmaceuticals, Inc. |
Phosphorus Derivatives as Kinase Inhibitors
|
|
GB0813403D0
(en)
|
2008-07-22 |
2008-08-27 |
Lectus Therapeutics Ltd |
Potassium ion channel modulators & uses thereof
|
|
EP2149551A1
(de)
|
2008-07-30 |
2010-02-03 |
Bayer Schering Pharma AG |
N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
DE102008061214A1
(de)
|
2008-12-09 |
2010-06-10 |
Merck Patent Gmbh |
Chinazolinamidderivate
|
|
EP2206712A1
(en)
|
2008-12-23 |
2010-07-14 |
CHIESI FARMACEUTICI S.p.A. |
"Alkaloid aminoester derivatives and medicinal composition thereof"
|
|
WO2010100144A1
(en)
|
2009-03-04 |
2010-09-10 |
Merck Serono S.A. |
Fused bicyclic compounds as inhibitors for pi3 kinase
|
|
JP5728683B2
(ja)
|
2009-09-04 |
2015-06-03 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
チロシンスレオニンキナーゼ阻害剤としての置換アミノキノキサリン
|
|
AU2010315152A1
(en)
|
2009-11-06 |
2012-06-14 |
Chelsea Therapeutics, Inc. |
Enzyme inhibiting compounds
|
|
WO2011113060A2
(en)
|
2010-03-12 |
2011-09-15 |
Trana Discovery, Inc. |
Antiviral compounds and methods of use thereof
|
|
AU2011306398A1
(en)
|
2010-09-24 |
2013-05-02 |
Ranbaxy Laboratories Limited |
Matrix metalloproteinase inhibitors
|
|
WO2012079032A2
(en)
|
2010-12-09 |
2012-06-14 |
Trana Discovery, Inc. |
Compositions and methods of treating drug-resistant retroviral infections
|
|
WO2012080729A2
(en)
|
2010-12-14 |
2012-06-21 |
Electrophoretics Limited |
CASEIN KINASE 1δ (CK1δ) INHIBITORS
|
|
GB201107176D0
(en)
|
2011-04-28 |
2011-06-15 |
Cxr Biosciences Ltd |
Pyrrolnitrin derivatives
|
|
WO2012172043A1
(en)
|
2011-06-15 |
2012-12-20 |
Laboratoire Biodim |
Purine derivatives and their use as pharmaceuticals for prevention or treatment of bacterial infections
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
NO3175985T3
(https=)
|
2011-07-01 |
2018-04-28 |
|
|
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
US9371320B2
(en)
|
2012-06-01 |
2016-06-21 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compound
|
|
US9853756B2
(en)
|
2012-11-07 |
2017-12-26 |
Qualcomm Incorporated |
Multicast over wireless network with the assistance of power-efficient peer group discovery
|
|
ES2648226T3
(es)
|
2012-11-08 |
2017-12-29 |
Bristol-Myers Squibb Company |
Compuestos de pirimidina sustituidos con alquilamida útiles en la modulación de IL-12, IL-23 y/o IFN
|
|
LT3495358T
(lt)
|
2012-11-08 |
2022-05-25 |
Bristol-Myers Squibb Company |
Amidais pakeisti heterocikliniai junginiai, naudingi kaip il-12, il-23 ir (arba) ifn alfa atsako moduliatoriai
|
|
KR102233252B1
(ko)
*
|
2012-11-08 |
2021-03-26 |
브리스톨-마이어스 스큅 컴퍼니 |
ＩＬ-12, ＩＬ-23 및/또는 ＩＦＮα 반응의 조절제로서 유용한 알킬-아미드-치환된 피리딜 화합물
|
|
WO2014120683A1
(en)
|
2013-01-29 |
2014-08-07 |
Children's Hospital Medical Center |
Small-molecule inhibitors targeting g-protein-coupled rho guanine nucleotide exchange factors
|
|
MX2015009952A
(es)
|
2013-02-08 |
2015-10-05 |
Celgene Avilomics Res Inc |
Inhibidores de cinasas reguladas por señales extracelulares (erk) y sus usos.
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2015013715A2
(en)
|
2013-07-26 |
2015-01-29 |
Thr Regents Of The University Of California |
C-h fluorination of heterocycles with silver (ii) fluoride
|
|
WO2015129927A1
(en)
|
2014-02-26 |
2015-09-03 |
Kyorin Pharmaceutical Co., Ltd. |
Heterocyclic compounds
|
|
GB201405359D0
(en)
|
2014-03-25 |
2014-05-07 |
Univ Liverpool |
Synthetic process
|
|
GB2533925A
(en)
|
2014-12-31 |
2016-07-13 |
Univ Bath |
Antimicrobial compounds, compositions and methods
|
|
TWI788655B
(zh)
|
2015-02-27 |
2023-01-01 |
美商林伯士拉克許米公司 |
酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途
|
|
WO2016149756A1
(en)
|
2015-03-23 |
2016-09-29 |
The University Of Melbourne |
Treatment of respiratory diseases
|
|
AU2016254385B2
(en)
|
2015-04-29 |
2018-05-10 |
Wuxi Fortune Pharmaceutical Co., Ltd |
JAK inhibitors
|
|
TW201705961A
(zh)
|
2015-06-11 |
2017-02-16 |
阿爾米雷爾有限公司 |
作為ｊａｋ抑制劑的２－（吡唑并吡啶－３－基）嘧啶衍生物
|
|
WO2016207345A1
(en)
|
2015-06-24 |
2016-12-29 |
Pierre Fabre Medicament |
3-amino-pyrazin-2-yl carboxamide and 2-amino-pyridin-3-yl carboxamide derivatives as polo-like kinase 1 (plk-1) inhibitors for the treatment of cancer
|
|
WO2017005832A1
(en)
|
2015-07-09 |
2017-01-12 |
Solvay Specialty Polymers Italy S.P.A. |
Process for the synthesis of (per)fluoropolyether amines
|
|
KR101726059B1
(ko)
|
2015-07-28 |
2017-04-12 |
한양대학교 산학협력단 |
디피롤 유도체와 암모늄 염을 포함하는 브롬화수소 가스 검출용 조성물 및 이를 포함하는 브롬화수소 가스 검출용 색변환 센서
|
|
KR101766961B1
(ko)
|
2015-07-28 |
2017-08-09 |
한양대학교 산학협력단 |
트리페닐이미다졸 유도체와 암모늄 염을 포함하는 메틸아민 가스 검출용 조성물 및 이를 포함하는 메틸아민 가스 검출용 색변환 센서
|
|
GB201513481D0
(en)
|
2015-07-30 |
2015-09-16 |
Univ Manchester |
Inhibitor compounds
|
|
JP6961879B2
(ja)
|
2015-12-30 |
2021-11-05 |
レ ラボラトワール セルヴィエ ソシエテ・パール・アクシオンス・サンプリフィエ |
変異体イソクエン酸デヒドロゲナーゼを包含する腫瘍の処置
|
|
PL3429591T3
(pl)
|
2016-03-16 |
2023-07-17 |
Kura Oncology, Inc. |
Podstawione pochodne tieno[2,3-d]pirymidyny jako inhibitory meniny-mll i metody ich zastosowania
|
|
KR102331438B1
(ko)
|
2016-04-06 |
2021-11-26 |
코닌클리케 필립스 엔.브이. |
임프린트 리소그래피 스탬프, 이의 제조 방법 및 사용 방법
|
|
CN105820175B
(zh)
|
2016-04-13 |
2019-09-20 |
四川大学 |
一种噻吩并嘧啶类化合物及其制备方法和应用
|
|
PL3442947T3
(pl)
|
2016-04-15 |
2023-10-02 |
Epizyme, Inc. |
Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2
|
|
EP4011882B1
(en)
|
2016-08-15 |
2025-03-05 |
Purdue Research Foundation |
4-substituted aminoisoquinoline derivatives
|
|
CN107880038B
(zh)
|
2016-09-30 |
2021-09-28 |
中国医药研究开发中心有限公司 |
[1,2,4]三唑并[1,5-a]吡啶类化合物及其制备方法和医药用途
|
|
US10323036B2
(en)
|
2016-10-14 |
2019-06-18 |
Nimbus Lakshmi, Inc. |
TYK2 inhibitors and uses thereof
|
|
GB201704327D0
(en)
|
2017-03-17 |
2017-05-03 |
Argonaut Therapeutics Ltd |
Compounds
|
|
US20200113901A1
(en)
|
2017-03-31 |
2020-04-16 |
Epizyme, Inc. |
Methods of using ehmt2 inhibitors
|
|
CN110621316B
(zh)
|
2017-04-21 |
2024-01-26 |
Epizyme股份有限公司 |
用ehmt2抑制剂进行的组合疗法
|
|
CN109020957B
(zh)
|
2017-06-12 |
2023-01-13 |
南京天印健华医药科技有限公司 |
作为mnk抑制剂的杂环化合物
|
|
EP3694861A4
(en)
|
2017-10-09 |
2021-05-19 |
Nuvation Bio Inc. |
HETEROCYCLIC COMPOUNDS AND USES THEREOF
|
|
AU2018353139A1
(en)
|
2017-10-18 |
2020-06-04 |
Epizyme, Inc. |
Methods of using EHMT2 inhibitors in immunotherapies
|
|
JP2021500326A
(ja)
|
2017-10-18 |
2021-01-07 |
エピザイム，インコーポレイティド |
血液障害の予防又は処置にｅｈｍｔ２阻害剤を使用する方法
|
|
GB201717260D0
(en)
|
2017-10-20 |
2017-12-06 |
Galapagos Nv |
Novel compounds and pharma ceutical compositions thereof for the treatment of inflammatory disorders
|
|
EA202091269A1
(ru)
|
2017-11-21 |
2020-08-07 |
Бристол-Маерс Сквибб Компани |
Сульфон-, пиридин-, алкил-, амид-замещенные гетероарильные соединения
|
|
JP7361693B2
(ja)
|
2017-12-15 |
2023-10-16 |
レヴォリューション・メディスンズ，インコーポレイテッド |
アロステリックｓｈｐ２阻害剤としての多環式化合物
|
|
WO2019165204A1
(en)
|
2018-02-23 |
2019-08-29 |
Newave Pharmaceutical Inc. |
1,2-dihydro-3h-pyrazolo[3,4-d]pyrimidine-3-one compounds as inhibitors of wee-1 kinase
|
|
CN112313205B
(zh)
|
2018-04-25 |
2023-12-26 |
南洋理工大学 |
共轭低聚电解质作为抗菌剂
|
|
US11485713B2
(en)
|
2018-05-25 |
2022-11-01 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for their use
|
|
US11945803B2
(en)
|
2018-08-07 |
2024-04-02 |
Tosk, Inc. |
Modulators of RAS GTPase
|
|
JP2021536458A
(ja)
|
2018-09-04 |
2021-12-27 |
マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. |
アリール炭化水素レセプター・アンタゴニスト及び使用方法
|
|
JP2022508651A
(ja)
|
2018-10-08 |
2022-01-19 |
レヴォリューション・メディスンズ，インコーポレイテッド |
癌を処置するためのｓｈｐ２阻害剤組成物および方法
|
|
JP7631193B2
(ja)
|
2018-10-22 |
2025-02-18 |
アルミス インコーポレイテッド |
Ｔｙｋ２阻害剤およびその使用
|
|
WO2020123675A1
(en)
|
2018-12-11 |
2020-06-18 |
Duke University |
Compositions and methods for the treatment of cancer
|
|
EP3673920A1
(en)
|
2018-12-28 |
2020-07-01 |
Universität Wien |
Polyphenol-peptide conjugates for nuclear-targeted delivery
|
|
CN115448910B
(zh)
|
2019-01-28 |
2024-04-19 |
江苏豪森药业集团有限公司 |
一种哒嗪类衍生物抑制剂、其制备方法和应用
|
|
CN111484480B
(zh)
*
|
2019-01-29 |
2023-08-11 |
上海翰森生物医药科技有限公司 |
一种多环类衍生物抑制剂、其制备方法和应用
|
|
GB201903085D0
(en)
|
2019-03-07 |
2019-04-24 |
Univ Oxford Innovation Ltd |
Passivation method
|
|
KR20210125558A
(ko)
|
2019-04-02 |
2021-10-18 |
하이노바 파마슈티컬스 인코포레이티드 |
방향족 아민계 화합물 및 이의 ar 및 brd4 이중 억제제 및 조절제의 제조에서의 용도
|
|
CN111909140A
(zh)
*
|
2019-04-12 |
2020-11-10 |
明慧医药（杭州）有限公司 |
作为tyk2抑制剂的杂环化合物及合成和使用方法
|
|
SG11202112043PA
(en)
|
2019-04-30 |
2021-11-29 |
Celgene Corp |
Combination therapies comprising apremilast and tyk2 inhibitors
|
|
CN112079830B
(zh)
|
2019-06-14 |
2023-12-22 |
上海翰森生物医药科技有限公司 |
含并环类衍生物抑制剂、其制备方法和应用
|
|
KR102877616B1
(ko)
|
2019-07-01 |
2025-10-28 |
삼성디스플레이 주식회사 |
조성물 및 이를 포함한 유기 발광 소자
|
|
WO2021001739A1
(en)
|
2019-07-02 |
2021-01-07 |
Effector Therapeutics, Inc. |
Translational enhancers and related methods
|
|
WO2021014453A1
(en)
|
2019-07-24 |
2021-01-28 |
Sol-Gel Technologies Ltd. |
Topical jak inhibitor combination compositions for treatment of inflammatory skin conditions
|
|
CN112409331B
(zh)
|
2019-08-21 |
2024-02-20 |
上海翰森生物医药科技有限公司 |
杂环类衍生物抑制剂、其制备方法和应用
|
|
JP7812785B2
(ja)
|
2019-09-18 |
2026-02-10 |
ブリストル－マイヤーズ スクイブ カンパニー |
Ｔｙｋ２阻害薬の剤形
|
|
CN112851579A
(zh)
|
2019-11-27 |
2021-05-28 |
衡阳师范学院 |
用于铜催化卤代芳烃偶联反应的配体化合物、催化体系和偶联反应
|
|
WO2021133917A1
(en)
|
2019-12-23 |
2021-07-01 |
Kymera Therapeutics, Inc. |
Smarca inhibitors and uses thereof
|
|
WO2021155253A1
(en)
|
2020-01-31 |
2021-08-05 |
Atomwise Inc. |
Anat inhibitors and methods of use thereof
|
|
SMT202400185T1
(it)
|
2020-03-11 |
2024-07-09 |
Beijing Innocare Pharma Tech Co Ltd |
Composti eterociclici per inibire attività di tyk2
|
|
KR20230004771A
(ko)
|
2020-04-28 |
2023-01-06 |
브리스톨-마이어스 스큅 컴퍼니 |
Il-12, il-23 및/또는 ifn알파 조정제로서의 치환된 n-(메틸-d3)피리다진-3-카르복스아미드 또는 n-(메틸-d3)-니코틴아미드 화합물
|
|
CA3186769A1
(en)
|
2020-06-11 |
2021-12-16 |
Betta Pharmaceuticals Co., Ltd |
Bicyclic compounds and use thereof
|
|
CN113968846A
(zh)
|
2020-07-24 |
2022-01-25 |
上海翰森生物医药科技有限公司 |
一种哒嗪类衍生物的盐、晶型及其制备方法和应用
|
|
CN115667246B
(zh)
|
2020-07-24 |
2024-08-23 |
上海翰森生物医药科技有限公司 |
一种哒嗪类衍生物自由碱的晶型及其制备方法和应用
|
|
US20220144842A1
(en)
|
2020-11-04 |
2022-05-12 |
Eternity Bioscience Inc. |
Irak inhibitors, preparation method and medicinal uses thereof
|
|
US20230416225A1
(en)
|
2020-11-09 |
2023-12-28 |
Merck Sharp & Dohme Llc |
Diaminopyrimidine carboxamide inhibitors of hpk1
|
|
US20240124440A1
(en)
|
2020-12-23 |
2024-04-18 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
US20240189309A1
(en)
|
2021-02-19 |
2024-06-13 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
EP4294806A1
(en)
*
|
2021-02-19 |
2023-12-27 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
CA3208361A1
(en)
|
2021-02-19 |
2022-08-25 |
Anjali Pandey |
Tyk2 inhibitors and uses thereof
|
|
AU2022222470A1
(en)
|
2021-02-19 |
2023-09-21 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|
|
JP2022143679A
(ja)
|
2021-03-18 |
2022-10-03 |
株式会社リコー |
光電変換素子、電子機器、及び電源モジュール
|
|
US12054506B2
(en)
|
2021-03-19 |
2024-08-06 |
Singular Genomics Systems, Inc. |
Reducing agents and uses thereof
|
|
WO2022226349A1
(en)
|
2021-04-22 |
2022-10-27 |
Essa Pharma, Inc. |
Androgen receptor modulators and methods for their use
|
|
WO2022232630A1
(en)
|
2021-04-30 |
2022-11-03 |
Board Of Regents, The University Of Texas System |
Use of carboxylates for carbon sequestration, improved oil recovery, and hydrogen storage and reproduction
|
|
JP2024518791A
(ja)
|
2021-05-14 |
2024-05-02 |
ブリストル－マイヤーズ スクイブ カンパニー |
置換ヘテロ環化合物
|
|
US20240317718A1
(en)
|
2021-05-14 |
2024-09-26 |
Bristol-Myers Squibb Company |
Substituted heterocyclic compounds
|
|
KR20240008337A
(ko)
|
2021-05-14 |
2024-01-18 |
브리스톨-마이어스 스큅 컴퍼니 |
치환된 헤테로시클릭 화합물
|
|
US11884650B2
(en)
|
2021-05-14 |
2024-01-30 |
Bristol-Myers Squibb Company |
Substituted heterocyclic compounds
|
|
PE20250262A1
(es)
|
2021-05-14 |
2025-01-29 |
Bristol Myers Squibb Co |
Compuestos heterociclicos sustituidos
|
|
WO2023227946A1
(en)
|
2022-05-27 |
2023-11-30 |
Sudo Biosciences Limited |
Tyk2 inhibitors and uses thereof
|